ORBIMED ADVISORS LLC Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ORBIMED ADVISORS LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in GLAUKOS Corp ($GKOS) and Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and in ACCELERON PHARMA INC ($XLRN) and Director in ProNAi Therapeutics Inc ($DNAI) and 10% Owner in AVEDRO INC ($AVDR) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in SI-BONE, Inc. ($SIBN) and Director in Xtant Medical Holdings, Inc. ($XTNT) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and Director in Otonomy, Inc. ($OTIC) and 10% Owner in Arsanis, Inc. ($ASNS) and 10% Owner in Principia Biopharma Inc. ($PRNB) and Director in Acutus Medical, Inc. ($AFIB) and Director in SYNLOGIC, INC. ($MIRN) and 10% Owner in NeuroPace Inc ($NPCE) and 10% Owner in GRAYBUG VISION, INC. ($GRAY) and 10% Owner in Sientra, Inc. ($SIEN) and 10% Owner in TELA Bio, Inc. ($TELA) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Dimension Therapeutics, Inc. ($DMTX) and 10% Owner in Guardant Health, Inc. ($GH) and 10% Owner in ViewRay, Inc. ($VRAY) and Director in ViewRay, Inc. ($VRAY) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and 10% Owner in Inspire Medical Systems, Inc. ($INSP) and Director in Inspire Medical Systems, Inc. ($INSP) and Director in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and Director in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Intellia Therapeutics, Inc. ($NTLA) and 10% Owner in Alector, Inc. ($ALEC) and Director in Alector, Inc. ($ALEC) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in NextCure, Inc. ($NXTC) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in IMARA Inc. ($IMRA) and Director in Keros Therapeutics, Inc. ($KROS) and Director in Prelude Therapeutics Inc ($PRLD) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in resTORbio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and Director in Edgewise Therapeutics, Inc. ($EWTX) and Director in 89bio, Inc. ($ETNB) and Director in Arcutis Biotherapeutics, Inc. ($ARQT) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Fusion Pharmaceuticals Inc. ($FUSN) and Director in Terns Pharmaceuticals, Inc. ($TERN) and Director in Ikena Oncology, Inc. ($IKNA).

Latest Insider Trading Transactions of ORBIMED ADVISORS LLC

Sentiment: All, ETNB, XLRN, AFIB, ADAP, TORC, AGLE, ARPO, ALEC, ALPN, ARQT, ARMO, BOLD, AVDR, CNST, CRVS, CTIC, DBTX, DMTX, EWTX, FUSN, GKOS, GRAY, GH, IKNA, IMRA, INSP, NTLA, ICPT, KALA, KROS, KNTE, LOGC, LOXO, NPCE, NXTC, ORIC, OTIC, PIRS, PMVP, PRLD, PRVL, PRNB, RLYP, RPTX, RPBIF, RYTM, SCPH, SELB, SIBN, SIEN, SRRA, SBTX, ROKA, SWTX, STDY, SYBX, THOR, TELA, TERN, TCDA, TPTX, VRAY, ASNS, XTNT

Page:   < prev 1 2 3 4 5 6 7 7 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 10 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerSellS9.862492,45582,03382.3 K to 82 K (-0.30 %)
Aug 10 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerSellS9.8626,139257,7318,614,1898.6 M to 8.6 M (-0.30 %)
Aug 10 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerSellS9.916156,09582,28282.9 K to 82.3 K (-0.74 %)
Aug 10 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerSellS9.9164,575639,9388,640,3288.7 M to 8.6 M (-0.74 %)
Aug 10 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerBuyM5.004312,15582,89782.5 K to 82.9 K (+0.52 %)
Aug 10 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerBuyM5.0045,203226,0158,704,9038.7 M to 8.7 M (+0.52 %)
Aug 10 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerBuyM5.0018492082,46682.3 K to 82.5 K (+0.22 %)
Aug 10 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerBuyM5.0019,37296,8608,659,7008.6 M to 8.7 M (+0.22 %)
Aug 10 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerSellS9.951,03610,30882,28283.3 K to 82.3 K (-1.24 %)
Aug 10 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerSellS9.95108,7291,081,8548,640,3288.7 M to 8.6 M (-1.24 %)
Aug 10 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerSellS10.004,55345,53083,31887.9 K to 83.3 K (-5.18 %)
Aug 10 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerSellS10.00478,1074,781,0708,749,0579.2 M to 8.7 M (-5.18 %)
Aug 10 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerBuyM0.00249087,87187.6 K to 87.9 K (+0.28 %)
Aug 10 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerBuyM0.0026,13909,227,1649.2 M to 9.2 M (+0.28 %)
Aug 07 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerSellS10.014784,78587,62288.1 K to 87.6 K (-0.54 %)
Aug 07 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerSellS10.0150,149501,9919,201,0259.3 M to 9.2 M (-0.54 %)
Aug 07 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerSellS11.711,12513,17488,10089.2 K to 88.1 K (-1.26 %)
Aug 07 2018VRAYViewRay, Inc.ORBIMED ADVISORS LLC10% OwnerSellS11.71118,1681,383,7479,251,1749.4 M to 9.3 M (-1.26 %)
Jul 24 2018CNSTCONSTELLATION PHAR ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseC0.003,500,00000
Jul 24 2018CNSTCONSTELLATION PHAR ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseC0.003,500,00000
Jul 24 2018CNSTCONSTELLATION PHAR ...ORBIMED ADVISORS LLC10% OwnerBuyP15.00100,0001,500,000417,921317.9 K to 417.9 K (+31.45 %)
Jul 24 2018CNSTCONSTELLATION PHAR ...ORBIMED ADVISORS LLC10% OwnerBuyC0.00317,9210317,9210 to 317.9 K
Jul 24 2018CNSTCONSTELLATION PHAR ...ORBIMED ADVISORS LLC10% OwnerBuyP15.00100,0001,500,000417,921317.9 K to 417.9 K (+31.45 %)
Jul 24 2018CNSTCONSTELLATION PHAR ...ORBIMED ADVISORS LLC10% OwnerBuyC0.00317,9210317,9210 to 317.9 K
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCOption ExerciseC0.004,255,31900
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCOption ExerciseC0.004,255,31900
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCOption ExerciseC0.0014,292,95800
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCOption ExerciseC0.0014,292,95800
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCOption ExerciseC0.0017,117,08500
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCOption ExerciseC0.0017,117,08500
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCOption ExerciseC0.006,207,67400
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCOption ExerciseC0.006,207,67400
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCBuyP19.00368,4216,999,99910,889,28010.5 M to 10.9 M (+3.50 %)
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCBuyP19.00368,4216,999,99910,889,28010.5 M to 10.9 M (+3.50 %)
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCBuyC0.001,069,175010,520,8599.5 M to 10.5 M (+11.31 %)
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCBuyC0.001,069,175010,520,8599.5 M to 10.5 M (+11.31 %)
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCBuyC0.003,591,19409,451,6845.9 M to 9.5 M (+61.28 %)
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCBuyC0.003,591,19409,451,6845.9 M to 9.5 M (+61.28 %)
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCBuyC0.004,300,77405,860,4901.6 M to 5.9 M (+275.74 %)
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCBuyC0.004,300,77405,860,4901.6 M to 5.9 M (+275.74 %)
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCBuyC0.001,559,71601,559,7160 to 1.6 M
Jul 02 2018TCDATricida, Inc.ORBIMED ADVISORS LLCBuyC0.001,559,71601,559,7160 to 1.6 M
Jul 02 2018ARPOAerpio Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP3.85777,5002,993,3755,193,9464.4 M to 5.2 M (+17.60 %)
Jun 22 2018ARMOARMO BioSciences, ...ORBIMED ADVISORS LLCDirectorSellU50.00409,54720,477,350409,547819.1 K to 409.5 K (-50.00 %)
Jun 22 2018ARMOARMO BioSciences, ...ORBIMED ADVISORS LLCDirectorSellU50.003,709,356185,467,8003,709,3567.4 M to 3.7 M (-50.00 %)
Jun 06 2018ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorSellS13.491,60021,5844,901,3104.9 M to 4.9 M (-0.03 %)
Jun 06 2018ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorSellS13.5717,100232,0474,902,9104.9 M to 4.9 M (-0.35 %)
Jun 01 2018ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorSellS13.4950,000674,5004,920,0105 M to 4.9 M (-1.01 %)
Jun 01 2018ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorSellS13.52121,0001,635,9204,970,0105.1 M to 5 M (-2.38 %)
May 24 2018RYTMRHYTHM PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerSellS30.961,60049,5362,750,0792.8 M to 2.8 M (-0.06 %)
May 24 2018RYTMRHYTHM PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerSellS30.3817,980546,2322,751,6792.8 M to 2.8 M (-0.65 %)
May 21 2018RYTMRHYTHM PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerSellS31.0162,5001,938,1252,769,6592.8 M to 2.8 M (-2.21 %)
May 21 2018RYTMRHYTHM PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerSellS30.7769,1362,127,3152,832,1592.9 M to 2.8 M (-2.38 %)
May 16 2018ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorSellS13.5010,300139,0505,091,0105.1 M to 5.1 M (-0.20 %)
May 09 2018INSPInspire Medical Sy ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseC0.003,649,63500
May 09 2018INSPInspire Medical Sy ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseC0.009,160,30500
May 09 2018INSPInspire Medical Sy ...ORBIMED ADVISORS LLC10% OwnerBuyP16.00312,5005,000,0002,444,2212.1 M to 2.4 M (+14.66 %)
May 09 2018INSPInspire Medical Sy ...ORBIMED ADVISORS LLC10% OwnerBuyC0.00548,81702,131,7211.6 M to 2.1 M (+34.67 %)
May 09 2018INSPInspire Medical Sy ...ORBIMED ADVISORS LLC10% OwnerBuyC0.001,582,90401,582,9040 to 1.6 M
May 02 2018PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerSellS6.3510,40066,04038,87049.3 K to 38.9 K (-21.11 %)
May 02 2018PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerSellS6.35989,6006,283,9604,511,1305.5 M to 4.5 M (-17.99 %)
Mar 29 2018ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorSellS11.5331,983368,7645,101,3105.1 M to 5.1 M (-0.62 %)
Mar 29 2018ADAPAdaptimmune Therap ...ORBIMED ADVISORS LLCDirectorSellS11.501,016,08411,684,9665,133,2936.1 M to 5.1 M (-16.52 %)
Mar 14 2018CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP8.50588,2354,999,9985,967,5845.4 M to 6 M (+10.94 %)
Mar 12 2018BOLDAudentes Therapeut ...ORBIMED ADVISORS LLC10% OwnerSellS34.9216,937591,4403,539,9973.6 M to 3.5 M (-0.48 %)
Mar 12 2018BOLDAudentes Therapeut ...ORBIMED ADVISORS LLC10% OwnerSellS36.041,06638,4193,556,9343.6 M to 3.6 M (-0.03 %)
Mar 12 2018BOLDAudentes Therapeut ...ORBIMED ADVISORS LLC10% OwnerSellS36.4411,305411,9543,558,0003.6 M to 3.6 M (-0.32 %)
Mar 12 2018BOLDAudentes Therapeut ...ORBIMED ADVISORS LLC10% OwnerSellS35.8647,3951,699,5853,569,3053.6 M to 3.6 M (-1.31 %)
Mar 12 2018BOLDAudentes Therapeut ...ORBIMED ADVISORS LLC10% OwnerSellS34.6721,300738,4713,616,7003.6 M to 3.6 M (-0.59 %)
Mar 12 2018BOLDAudentes Therapeut ...ORBIMED ADVISORS LLC10% OwnerSellS34.0658,4281,990,0583,638,0003.7 M to 3.6 M (-1.58 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS32.0644514,2670445 to 0 (-100.00 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS32.0646,6761,496,433046.7 K to 0 (-100.00 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS30.771925,908445637 to 445 (-30.14 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS30.7720,114618,90846,67666.8 K to 46.7 K (-30.12 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS30.0188626,5896371.5 K to 637 (-58.17 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS30.0193,0082,791,17066,790159.8 K to 66.8 K (-58.20 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS33.0676825,3901,5232.3 K to 1.5 K (-33.52 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS33.0680,5162,661,859159,798240.3 K to 159.8 K (-33.50 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS32.051,22039,1012,2913.5 K to 2.3 K (-34.75 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS32.05128,0924,105,349240,314368.4 K to 240.3 K (-34.77 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS32.801,85160,7133,5115.4 K to 3.5 K (-34.52 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS32.80194,4336,377,402368,406562.8 K to 368.4 K (-34.55 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS31.922,53380,8535,3627.9 K to 5.4 K (-32.08 %)
Mar 06 2018GKOSGLAUKOS CorpORBIMED ADVISORS LLCDirectorSellS31.92265,7668,483,251562,839828.6 K to 562.8 K (-32.07 %)
Mar 06 2018BOLDAudentes Therapeut ...ORBIMED ADVISORS LLC10% OwnerSellS33.0311,372375,6173,696,4283.7 M to 3.7 M (-0.31 %)
Mar 06 2018BOLDAudentes Therapeut ...ORBIMED ADVISORS LLC10% OwnerSellS36.062007,2123,707,8003.7 M to 3.7 M (-0.01 %)
Mar 06 2018BOLDAudentes Therapeut ...ORBIMED ADVISORS LLC10% OwnerSellS36.3335,5581,291,8223,708,0003.7 M to 3.7 M (-0.95 %)
Mar 06 2018BOLDAudentes Therapeut ...ORBIMED ADVISORS LLC10% OwnerSellS35.06386,08013,535,9653,743,5584.1 M to 3.7 M (-9.35 %)
Feb 23 2018XTNTXtant Medical Hold ...ORBIMED ADVISORS LLCDirectorOption ExerciseD34.80809,61428,174,5670
Feb 23 2018XTNTXtant Medical Hold ...ORBIMED ADVISORS LLCDirectorOption ExerciseD34.801,428,55349,713,6440
Feb 23 2018XTNTXtant Medical Hold ...ORBIMED ADVISORS LLCDirectorOption ExerciseD46.5618,810,000875,793,6000
Feb 23 2018XTNTXtant Medical Hold ...ORBIMED ADVISORS LLCDirectorOption ExerciseD46.5633,190,0001,545,326,4000
Feb 23 2018XTNTXtant Medical Hold ...ORBIMED ADVISORS LLCDirectorBuyP7.20342,1322,463,3503,316,1283 M to 3.3 M (+11.50 %)
Feb 23 2018XTNTXtant Medical Hold ...ORBIMED ADVISORS LLCDirectorBuyP7.20603,6874,346,5465,890,8845.3 M to 5.9 M (+11.42 %)
Feb 23 2018XTNTXtant Medical Hold ...ORBIMED ADVISORS LLCDirectorGrantA7.202,905,39620,918,8512,973,99668.6 K to 3 M (+4,235.27 %)
Feb 23 2018XTNTXtant Medical Hold ...ORBIMED ADVISORS LLCDirectorGrantA7.205,126,53436,911,0455,287,197160.7 K to 5.3 M (+3,190.86 %)
Feb 15 2018PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM5.0817860
Feb 15 2018PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM5.081,7658,9660
Feb 15 2018PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM4.68582710
Feb 15 2018PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM4.686,05728,3470
Feb 15 2018PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerSellS8.987567449,27049.3 K to 49.3 K (-0.15 %)
Feb 15 2018PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerSellS8.987,82270,2425,500,7305.5 M to 5.5 M (-0.14 %)
Feb 15 2018PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM5.08178649,34549.3 K to 49.3 K (+0.03 %)
Feb 15 2018PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM5.081,7658,9665,508,5525.5 M to 5.5 M (+0.03 %)
Feb 15 2018PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM4.685827149,32849.3 K to 49.3 K (+0.12 %)
Feb 15 2018PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerBuyM4.686,05728,3475,506,7875.5 M to 5.5 M (+0.11 %)
Feb 06 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.7337,840557,3833,422,8403.4 M to 3.4 M (+1.12 %)
Feb 02 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9922,840342,3723,385,0003.4 M to 3.4 M (+0.68 %)
Feb 02 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP15.00339,4005,091,0003,362,1603 M to 3.4 M (+11.23 %)
Jan 30 2018TORCresTORbio, Inc.ORBIMED ADVISORS LLCDirectorOption ExerciseC0.001,871,56900
Jan 30 2018TORCresTORbio, Inc.ORBIMED ADVISORS LLCDirectorOption ExerciseC0.002,425,48200
Jan 30 2018TORCresTORbio, Inc.ORBIMED ADVISORS LLCDirectorBuyP15.00533,3337,999,9954,830,3874.3 M to 4.8 M (+12.41 %)
Jan 30 2018TORCresTORbio, Inc.ORBIMED ADVISORS LLCDirectorBuyC0.001,871,56904,297,0542.4 M to 4.3 M (+77.16 %)
Jan 30 2018TORCresTORbio, Inc.ORBIMED ADVISORS LLCDirectorBuyC0.002,425,48502,425,4850 to 2.4 M
Jan 30 2018ARMOARMO BioSciences, ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.0031,31500
Jan 30 2018ARMOARMO BioSciences, ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.0045,96100
Jan 30 2018ARMOARMO BioSciences, ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.00332,27100
Jan 30 2018ARMOARMO BioSciences, ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.00283,62700
Jan 30 2018ARMOARMO BioSciences, ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.00415,86900
Jan 30 2018ARMOARMO BioSciences, ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.001,226,15600
Jan 30 2018ARMOARMO BioSciences, ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.001,783,70400
Jan 30 2018ARMOARMO BioSciences, ...ORBIMED ADVISORS LLCDirectorBuyC0.00409,5470409,5470 to 409.5 K
Jan 30 2018ARMOARMO BioSciences, ...ORBIMED ADVISORS LLCDirectorBuyC0.003,709,35603,709,3560 to 3.7 M
Jan 30 2018MIRNSYNLOGIC, INC.ORBIMED ADVISORS LLCDirectorGrantA9.75715,0006,971,2502,029,9961.3 M to 2 M (+54.37 %)
Jan 30 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9950,000749,5003,022,7603 M to 3 M (+1.68 %)
Jan 30 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9322,760339,8072,972,7603 M to 3 M (+0.77 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9164,637963,7382,950,0002.9 M to 3 M (+2.24 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.994,36365,4012,885,3632.9 M to 2.9 M (+0.15 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9875,0001,123,5002,881,0002.8 M to 2.9 M (+2.67 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9574,9311,120,2182,806,0002.7 M to 2.8 M (+2.74 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.5038,354556,1332,731,0692.7 M to 2.7 M (+1.42 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9164,637963,7382,950,0002.9 M to 3 M (+2.24 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.994,36365,4012,885,3632.9 M to 2.9 M (+0.15 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9875,0001,123,5002,881,0002.8 M to 2.9 M (+2.67 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.9574,9311,120,2182,806,0002.7 M to 2.8 M (+2.74 %)
Jan 24 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP14.5038,354556,1332,731,0692.7 M to 2.7 M (+1.42 %)
Jan 12 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP15.4028,446438,0682,692,7152.7 M to 2.7 M (+1.07 %)
Jan 12 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP13.6541,700569,2052,664,2692.6 M to 2.7 M (+1.59 %)
Jan 12 2018KALAKala Pharmaceutica ...ORBIMED ADVISORS LLC10% OwnerBuyP12.83170,3382,185,4372,622,5692.5 M to 2.6 M (+6.95 %)
Jan 04 2018PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerSellS7.3516,128118,54149,27065.4 K to 49.3 K (-24.66 %)
Jan 04 2018PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerSellS7.351,693,49212,447,1665,500,7307.2 M to 5.5 M (-23.54 %)
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM5.64472650
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM5.644,97128,0360
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM2.32992300
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM2.3210,44724,2370
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM2.01971950
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM2.0110,21620,5340
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM2.011422850
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM2.0114,85829,8650
Dec 20 2017PIRSPIERIS PHARMACEUTI ...ORBIMED ADVISORS LLC10% OwnerOption ExerciseM1.64971590

Page:   < prev 1 2 3 4 5 6 7 7 next >

Contact us | Follow us on Twitter